Mustang Bio Inc.

NASDAQ: MBIOHealthcare / Biotechnology / -
3.25+0.0500+1.56%Vol 60 4571Y Perf -56.49%
Jul 19th, 2019 16:00
BID3.23 ASK3.25
Open3.17 Previous Close3.20
Pre-Market- After-Trading-
 - -%  - -%
Target Price
12.50 
Analyst Rating
Strong Buy 1.00
Potencial %
284.62 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/100 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/-/100 
Income Ranking
 —    -
Market Cap (mil)131 
Earnings Rating
Strong Buy
Price Range Ratio 52wk %
13.34 
Earnings Date
12th Aug 2019

Today's Price Range

3.133.29

52wk Range

2.1810.20

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Neutral
Performance
1 Week
-4.41%
1 Month
-3.56%
3 Months
-42.38%
6 Months
-1.81%
1 Year
-56.49%
3 Years
-
5 Years
-
10 Years
-

Name / TickerPriceChg.Chg.%
MBIO3.250.05001.56
AAPL202.59-3.0700-1.49
GOOG1 130.10-16.2300-1.42
MSFT136.620.20000.15
XOM74.990.15000.20
WFC46.030.21000.46
JNJ130.31-1.7600-1.33
FB198.36-2.4200-1.21
GE10.04-0.0200-0.20
JPM113.54-1.1300-0.99
Earnings HistoryEstimateReportedSurprise %
Q01 2019-0.37-0.348.11
Q04 2018-0.27-0.44-62.96
Q03 2018-0.20-0.28-40.00
Q02 2018-0.25-0.1924.00
Q01 2018-0.23-0.24-4.35
Q04 2017-0.24-0.228.33
----
----
Earnings Per EndEstimateRevision %Trend
6/2019 QR-0.2431.43Positive
9/2019 QR-0.2435.14Positive
12/2019 FY-1.1023.61Positive
12/2020 FY-1.0129.37Positive
Next Report Date12th Aug 2019
Estimated EPS Next Report-0.24
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume60 457
Shares Outstanding (in ths.)40 258
Trades Count210
Dollar Volume156 361
Avg. Volume574 968
Avg. Weekly Volume105 190
Avg. Monthly Volume255 208
Avg. Quarterly Volume580 466
Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (100.00 %)
1 (100.00 %)
1 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Mustang Bio Inc.

Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on the acquisition, development, and commercialization of novel cancer immunotherapy products designed to utilize the power of the patient's own immune system to eliminate cancer cells. The products under development are - CD123, CD20, and CS1.

CEO: Manuel Litchman

Teplephone: +1 781 652-4500

Address: 2 Gansevoort Street, New York 10014, NY, USA

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

0%100%

Bearish Bullish

86%14%

Bearish Bullish

56%44%

Bearish Bullish

57%43%

News